IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 1 filers reported holding IVERIC BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $2,010 | -42.0% | 51,101 | -64.1% | 0.09% | -47.0% |
Q1 2023 | $3,466 | +3.2% | 142,441 | -9.2% | 0.16% | -11.8% |
Q4 2022 | $3,359 | -99.9% | 156,900 | -12.9% | 0.19% | -4.6% |
Q3 2022 | $3,233,000 | +104.4% | 180,210 | +9.6% | 0.20% | +63.9% |
Q2 2022 | $1,582,000 | +99.7% | 164,468 | +249.4% | 0.12% | +128.8% |
Q1 2022 | $792,000 | +230.0% | 47,078 | +228.2% | 0.05% | +73.3% |
Q4 2021 | $240,000 | -53.1% | 14,344 | -54.5% | 0.03% | -55.9% |
Q3 2021 | $512,000 | +279.3% | 31,521 | +46.9% | 0.07% | +51.1% |
Q2 2021 | $135,000 | -66.2% | 21,457 | -66.8% | 0.04% | -64.8% |
Q1 2021 | $399,000 | -71.2% | 64,547 | -67.8% | 0.13% | -67.6% |
Q4 2020 | $1,386,000 | +15.8% | 200,521 | -5.5% | 0.40% | +3.9% |
Q3 2020 | $1,197,000 | +407.2% | 212,261 | +358.9% | 0.38% | +375.0% |
Q2 2020 | $236,000 | +84.4% | 46,254 | +24.4% | 0.08% | +48.1% |
Q1 2020 | $128,000 | – | 37,170 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 1,729,041 | $10,685,000 | 4.26% |
Soleus Capital Management, L.P. | 3,380,979 | $20,894,000 | 3.76% |
ACUTA CAPITAL PARTNERS, LLC | 1,579,093 | $9,759,000 | 3.52% |
Stonepine Capital Management, LLC | 875,180 | $5,409,000 | 2.92% |
Samsara BioCapital, LLC | 2,372,476 | $14,664,000 | 2.70% |
Ghost Tree Capital, LLC | 1,125,000 | $6,953,000 | 1.63% |
Octagon Capital Advisors LP | 680,036 | $4,203,000 | 1.58% |
Altium Capital Management LP | 902,633 | $5,578,000 | 1.55% |
Vivo Capital, LLC | 5,966,527 | $36,873,000 | 1.30% |
FRAZIER MANAGEMENT LLC | 2,544,500 | $15,725,000 | 1.26% |